Tocilizumab in the treatment of rapidly evolving COVID-19 pneumonia and multifaceted critical illness: A retrospective case series.

Ann Med Surg (Lond) · 2020 · PMC7642808 · PMID 33169088

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significancep = 0.08so close (0.05 < p ≤ 0.1)

Survival on day-14 post-ICU admission was higher in the non-mechanically ventilated group of patients compared to the mechanically ventilated patients but did not reach statistical significance [hazard ratio: 2.6, 95% CI: 0.9–7.7, p = 0.08].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.